Triazolo compounds as mmp inhibitors
CA 2437588 A1 · Owner: Warner Lambert Company Llc · Inventors: Gaudilliere, Bernard; Andrianjara, Charles; Jacobelli, Henry
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A compound selected from those of formula (I): in which: W represents N or C- R1; in which R1 is as defined in the description X represents N or C-R2 in , which R2 is as defined in the description Y represents a group selected from , oxygen sulfur, -NH, and -Nalkyl, Z represents a group selected from oxygen sulphur, -NR8 in which R8 is as defined in the description and optionally , carbon depending the definition of Y n is an integer from 0 to 8 inclusive, Z1 represents a group -CR9R10 wherein R9 and R10 are as defined in the , description, which group contains optionally multiple bonds or heteroatomes A , represents a cyclic group, m is an integer from 0 to 7 inclusive the group(s) , R4 is …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 11, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 11, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 11, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.